Filed: 5/15/2025ACC: 0001553936-25-000007
📋 What this filing means
TYBOURNE CAPITAL MANAGEMENT (HK) LTD filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $23.56M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$23.56M
Total AUM (reported)
8.76M
Total Shares
Allocation by class
COM$8.71M37.0%
COM SHS$5.14M21.8%
SPONSORED ADS$4.89M20.8%
COM NEW$4.81M20.4%
Portfolio Concentration
Top 3$17.22M73.1%
4–10$6.34M26.9%
Top 3 weight
73.1%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 8.76M
Sole
Full voting authority
8.76M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole5
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings5
Rows:
ACELYRIN INC (SLRN US)
SOLEShares2.91M
TypeSH
Market value$7.18M
30.48%
Sole
2.91M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC (TSHA US)
SOLEShares3.70M
TypeSH
Market value$5.14M
21.83%
Sole
3.70M
Shared
0.00
None
0.00
BICYCLE THERAPEUTICS LTD-ADR (BCYC US)
SOLEShares576.34K
TypeSH
Market value$4.89M
20.77%
Sole
576.34K
Shared
0.00
None
0.00
FORTE BIOSCIENCES INC (FBRX US)
SOLEShares619.98K
TypeSH
Market value$4.81M
20.42%
Sole
619.98K
Shared
0.00
None
0.00
ZENTALIS PHARMACEUTICALS INC (ZNTL US)
SOLEShares961.49K
TypeSH
Market value$1.53M
6.49%
Sole
961.49K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
ACELYRIN INC (SLRN US)SOLE | COM | 2.91M | SH | $7.18M 30.48% | 2.91M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INC (TSHA US)SOLE | COM SHS | 3.70M | SH | $5.14M 21.83% | 3.70M | 0.00 | 0.00 |
BICYCLE THERAPEUTICS LTD-ADR (BCYC US)SOLE | SPONSORED ADS | 576.34K | SH | $4.89M 20.77% | 576.34K | 0.00 | 0.00 |
FORTE BIOSCIENCES INC (FBRX US)SOLE | COM NEW | 619.98K | SH | $4.81M 20.42% | 619.98K | 0.00 | 0.00 |
ZENTALIS PHARMACEUTICALS INC (ZNTL US)SOLE | COM | 961.49K | SH | $1.53M 6.49% | 961.49K | 0.00 | 0.00 |